FI883708A - Menetelmä emäksisten proteiinien eristämiseksi proteiiniseoksista, jotka sisältävät tällaisia emäksisiä proteiineja - Google Patents

Menetelmä emäksisten proteiinien eristämiseksi proteiiniseoksista, jotka sisältävät tällaisia emäksisiä proteiineja Download PDF

Info

Publication number
FI883708A
FI883708A FI883708A FI883708A FI883708A FI 883708 A FI883708 A FI 883708A FI 883708 A FI883708 A FI 883708A FI 883708 A FI883708 A FI 883708A FI 883708 A FI883708 A FI 883708A
Authority
FI
Finland
Prior art keywords
basic proteins
protein mixtures
mixtures containing
isolating
proteins
Prior art date
Application number
FI883708A
Other languages
English (en)
Swedish (sv)
Other versions
FI91875B (fi
FI91875C (fi
FI883708A0 (fi
Inventor
Michael Doerschug
Rainer Obermeier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI883708A0 publication Critical patent/FI883708A0/fi
Publication of FI883708A publication Critical patent/FI883708A/fi
Publication of FI91875B publication Critical patent/FI91875B/fi
Application granted granted Critical
Publication of FI91875C publication Critical patent/FI91875C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI883708A 1987-08-11 1988-08-09 Menetelmä emäksisten proteiinien eristämiseksi proteiiniseoksista, jotka sisältävät tällaisia emäksisiä proteiineja FI91875C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873726655 DE3726655A1 (de) 1987-08-11 1987-08-11 Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten
DE3726655 1987-08-11

Publications (4)

Publication Number Publication Date
FI883708A0 FI883708A0 (fi) 1988-08-09
FI883708A true FI883708A (fi) 1989-02-12
FI91875B FI91875B (fi) 1994-05-13
FI91875C FI91875C (fi) 1994-08-25

Family

ID=6333496

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883708A FI91875C (fi) 1987-08-11 1988-08-09 Menetelmä emäksisten proteiinien eristämiseksi proteiiniseoksista, jotka sisältävät tällaisia emäksisiä proteiineja

Country Status (19)

Country Link
US (1) US5101013A (fi)
EP (1) EP0305760B1 (fi)
JP (1) JP2587867B2 (fi)
KR (1) KR0129539B1 (fi)
AT (1) ATE96447T1 (fi)
AU (1) AU609170B2 (fi)
CA (1) CA1340237C (fi)
DE (2) DE3726655A1 (fi)
DK (1) DK173502B1 (fi)
ES (1) ES2047007T3 (fi)
FI (1) FI91875C (fi)
HU (1) HU198218B (fi)
IE (1) IE61557B1 (fi)
IL (1) IL87385A (fi)
NO (1) NO175004C (fi)
NZ (1) NZ225746A (fi)
PH (1) PH26874A (fi)
PT (1) PT88230B (fi)
ZA (1) ZA885871B (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0600372B1 (de) * 1992-12-02 1997-02-05 Hoechst Aktiengesellschaft Verfahren zur Gewinnung von Proinsulin mit korrekt verbundenen Cystinbrücken
ES2218622T3 (es) 1996-07-26 2004-11-16 Aventis Pharma Deutschland Gmbh Derivados de insulina con actividad de union al zinc incrementada.
DE19652713C2 (de) * 1996-12-18 2001-11-22 Aventis Pharma Gmbh Verfahren zur Reinigung von Insulin und Insulinderivaten durch Chromatographie an stark saurem Kationenaustauscher
KR100341297B1 (ko) * 1997-03-29 2002-11-16 주식회사종근당 재조합활성형프로인슐린의분리.정제방법
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
US6451987B1 (en) * 1999-03-15 2002-09-17 Novo Nordisk A/S Ion exchange chromatography of proteins and peptides
EP2348044A1 (en) * 1999-03-15 2011-07-27 Novo Nordisk A/S Ion exchange chromatography of GLP-1, analogs and derivatives thereof
US6444788B1 (en) 1999-03-15 2002-09-03 Novo Nordisk A/S Ion exchange chromatography of GLP-1, analogs and derivatives thereof
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
SE0300791D0 (sv) * 2003-03-20 2003-03-20 Amersham Biosciences Ab Use of ph-responsive polymers
CA2532340A1 (en) * 2003-08-21 2005-03-03 Novo Nordisk A/S Separation of polypeptides comprising a racemized amino acid
KR101039353B1 (ko) * 2005-08-04 2011-06-08 도요 세이칸 가부시키가이샤 플라스틱 보틀 살균 방법
HUE037449T2 (hu) 2008-10-17 2018-08-28 Sanofi Aventis Deutschland Egy inzulin és egy GLP-1 agonista kombinációja
FR2947818B1 (fr) * 2009-07-09 2011-07-29 Inst Superieur Des Sciences Agronomiques Agroalimentaires Horticoles Et Du Paysage Agro Campus Ouest Utilisation d'un coproduit issu d'un procede d'extraction du lysozyme a partir de blanc d'oeuf, pour l'obtention d'au moins une proteine basique de blanc d'oeuf
PE20121316A1 (es) 2009-11-13 2012-10-05 Sanofi Aventis Deutschland Composicion farmaceutica que comprende un agonista de glp-1 y metionina
RU2537239C2 (ru) 2009-11-13 2014-12-27 Санофи-Авентис Дойчланд Гмбх Фармацевтическая композиция, включающая агонист glp-1, инсулин и метионин
PT2611458T (pt) 2010-08-30 2016-12-16 Sanofi Aventis Deutschland Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PT2750699E (pt) 2011-08-29 2015-11-03 Sanofi Aventis Deutschland Acelerómetro pendular
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
PL2748181T3 (pl) 2011-09-30 2016-08-31 Ge Healthcare Bioprocess R&D Ab Sposób oczyszczania rozszczepionej proinsuliny
EP2931301B2 (en) 2012-12-17 2021-09-15 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
US10407483B2 (en) 2014-03-14 2019-09-10 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
CA2970200A1 (en) 2014-12-12 2016-06-16 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
JPWO2018147393A1 (ja) * 2017-02-10 2019-11-21 三菱ケミカル株式会社 ヒトインスリン精製用分離剤及びヒトインスリンの精製方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2629568C3 (de) * 1976-07-01 1981-09-10 Hoechst Ag, 6000 Frankfurt Verfahren zur Reinigung von Insulin, seinen Analogen und Derivaten
NL7713966A (nl) * 1976-12-27 1978-06-29 Univ Minnesota Werkwijze voor het behandelen van insuline.
DK311477A (da) * 1977-07-08 1979-01-09 Leo Lab Fremgangsmaade ved fremstilling af rent insulin
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
DD247684A1 (de) * 1983-04-14 1987-07-15 Ulrich Krabiell Verfahren zur isolierung von insulinderivaten
EP0123228B1 (en) * 1983-04-25 1993-09-29 Chiron Corporation Hybrid dna synthesis of mature insulin-like growth factors
DE3440988A1 (de) * 1984-11-09 1986-07-10 Hoechst Ag, 6230 Frankfurt Verfahren zur spaltung von peptiden und proteinen an der methionyl-bindung
DE3511269A1 (de) * 1985-04-12 1986-10-09 Veb Berlin-Chemie, Ddr 1199 Berlin Verfahren zur reinigung von insulin
JPS6379591A (ja) * 1986-09-22 1988-04-09 Mitsui Toatsu Chem Inc ｔＰＡの精製方法
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0365858B1 (en) * 1988-10-26 1994-11-30 American Cyanamid Company Process for reducing the aggregate content of growth hormone-like materials

Also Published As

Publication number Publication date
NZ225746A (en) 1990-11-27
JPS6486896A (en) 1989-03-31
NO883554D0 (no) 1988-08-10
AU609170B2 (en) 1991-04-26
NO175004C (no) 1994-08-17
IL87385A0 (en) 1989-01-31
DK447688A (da) 1989-02-12
HU198218B (en) 1989-08-28
CA1340237C (en) 1998-12-15
FI91875B (fi) 1994-05-13
FI91875C (fi) 1994-08-25
HUT47958A (en) 1989-04-28
KR0129539B1 (ko) 1998-04-04
NO175004B (no) 1994-05-09
ATE96447T1 (de) 1993-11-15
EP0305760B1 (de) 1993-10-27
ZA885871B (en) 1989-04-26
EP0305760A2 (de) 1989-03-08
IE882441L (en) 1989-02-11
PT88230A (pt) 1989-06-30
DK447688D0 (da) 1988-08-10
PH26874A (en) 1992-11-16
DE3885214D1 (de) 1993-12-02
IE61557B1 (en) 1994-11-16
DK173502B1 (da) 2001-01-08
EP0305760A3 (en) 1990-06-06
AU2059188A (en) 1989-02-16
PT88230B (pt) 1995-03-01
FI883708A0 (fi) 1988-08-09
IL87385A (en) 1993-08-18
ES2047007T3 (es) 1994-02-16
KR890003799A (ko) 1989-04-18
DE3726655A1 (de) 1989-02-23
NO883554L (no) 1989-02-13
US5101013A (en) 1992-03-31
JP2587867B2 (ja) 1997-03-05

Similar Documents

Publication Publication Date Title
FI883708A (fi) Menetelmä emäksisten proteiinien eristämiseksi proteiiniseoksista, jotka sisältävät tällaisia emäksisiä proteiineja
DK38189A (da) Hidtil ukendte fusionsproteiner indeholdende glutation-s-transferase
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
DK0620709T3 (da) Fremgangsmåde til isolering af lactoferrin og lactoperoxidase fra mælk og mælkeprodukter
CY1112195T1 (el) Μεθοδος παρασκευης ενος πεπτιδιου με pl πανω απο 8 ή κατω απο 5
ATE113960T1 (de) Proteingewinnung.
PT81624A (en) Recombinant methods for production of serine protease inhibitors and method for isolation of same
Terao et al. Studies on structural proteins of the rat liver ribosomes I. Molecular weights of the proteins of large and small subunits
DK610888A (da) Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
GB9019919D0 (en) Purification of proteins
Matsumura et al. Fat metabolism in higher plants: XXXV. Partial primary structure of spinach acyl carrier protein
Grimbleby et al. Binding of trichloroacetic acid by protein
KR880014107A (ko) 안지오게닌의 유전공학적 제조방법
UA27771C2 (uk) Електролітична комірка (варіанти) та спосіб мічення протеїнів, пептидів і інших органічних молекул
DK319384A (da) 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
Hossain et al. Purification and subunit structure of tryptophanyl tRNA synthetase (TRS) from baker's yeast
DE209855T1 (de) Aminosaeure-derivate, nuetzlich zur deaktivation von enzymen.
Takeshima et al. Ribosomal proteins of sea urchin eggs. I. Characterization of cytoplasmic ribosomal proteins
IJzerman et al. A refined method for the photoaffinity labelling of the nitrobenzylthioinosine-sensitive nucleoside transport protein: application to cell membranes of calf lung tissue
Koichi et al. Separation of Two Different Heavy Meromyosins
Kristoffersen et al. Identification of 20β-Hydroxy-pregn-4-ene-3-one in Luteal Tissue from Pregnant Whales
ES531495A0 (es) Procedimiento para preparar un hidrolizado proteinico
FI934079A (fi) Menetelmä fuusioproteiinin valmistamiseksi
ES2125175A1 (es) Proteina inactivadora de ribosomas, denominada nigrina b basica, de la planta sambucus nigra l., procedimiento para su obtencion y preparacion.

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: AVENTIS PHARMA DEUTSCHLAND GMBH

PC Transfer of assignment of patent

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH

Free format text: SANOFI-AVENTIS DEUTSCHLAND GMBH

MA Patent expired